MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202411093050 A) filed by University Of Lucknow on November 28, 2024, for A Composition Of Anti-Lung Adenocarcinoma Drugs Epdx And Dhdx And Its Method Of Preparation.
Inventors include Farheen Jameel; Priyanka Agarwal; Rumana Ahmad; Sahabjada Siddiqui; and M. Serajuddin.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention relates to the composition of anti-lung adenocarcinoma drugs EPDx and DHDx and its method of preparation. The composition comprises combinations of EPA-Doxorubicin and DHA-Doxorubicin with consistent ratios. The formulation provides synergistic effects in lung adenocarcinoma (A549 cell line). This formulation maximizes the therapeutic effects while minimizing toxicity.
Disclaimer: Curated by HT Syndication.
